Apple's revenue exploded 399% to $265.6B while share count declined significantly, accompanied by the launch of next-generation iPhone 17 and Apple Watch Series 11 product lines.
The massive revenue surge combined with reduced share count suggests either a major acquisition, significant business expansion, or potential data reporting changes that require immediate investor attention. The introduction of iPhone 17 Pro, iPhone Air, and refreshed Apple Watch lineup indicates Apple has successfully executed its next product cycle, though the magnitude of financial changes is unprecedented for Apple's typically steady growth pattern.
Apple delivered extraordinary financial performance with revenue surging 399% to $265.6B while maintaining disciplined operations through 22% inventory reduction and 29% stockholders equity growth. Net income grew a more modest 19% to $112B, suggesting either higher costs from the massive revenue expansion or one-time factors, while increased R&D spending (+10%) and capex (+35%) signal continued investment in future growth. The company strengthened its balance sheet with 20% higher cash reserves and improved receivables, but the disconnect between massive revenue growth and moderate profit growth warrants close examination of the underlying business drivers.
Strong top-line growth of 398.6% — accelerating demand or successful expansion into new markets.
Capital expenditure jumped 34.6% — major investment cycle underway; assess returns on deployment.
Interest expense surged 34.2% — significant debt increase or rising rates materially impacting earnings.
Equity base grew 29.5% — retained earnings accumulation or equity issuance strengthening the balance sheet.
Inventory reduced 21.5% — lean inventory management or demand outpacing supply.
Cash grew 20% — improving liquidity position supports investment and shareholder returns.
Net income grew 19.5% — bottom-line growth signals improving overall business health.
Receivables grew 19.1% — monitor days sales outstanding for collection efficiency.
R&D investment increased 10.1% — signals commitment to future product development, though near-term margin impact.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →